CAS: 10118-90-8; (4S,4As,5Ar,12As)-4,7-Bis(Dimethylamino)-3,10,12,12A-Tetrahydroxy-1,11-Dioxo-1,4,4A,5,5A,6,11,12A-Octahydrotetracene-2-Carboxamide

该化合物是一个复杂的有机化合物,其特征是其多环结构和多种功能组.该物质具有氯化萘脊椎特征,有助于其芳香特性,代之以碳箱胺组,增强其溶解性和再活动.二甲基氨基化合物的存在表明其潜在基础性以及形成氢结的能力,这可能影响其生物活动.该化合物还包含若干氢气基组,可参与氢联结,并可能影响其与其他分子的相互作用.该化合物的立体化学特征,以各乳房中心的具体配置为标志,表明它可能具有独特的药性特性.

结构式图片

上下游产品

CAS号13614-98-7 盐酸米诺环素 | CAS号993-50-0 (二甲基氨基)三甲基锡 | CAS号113164-67-3 7-iodosancycline | CAS号149934-19-0 9-Animomin°Cycline

合成工艺路线路线简述

  • 合成目标产物 Minocycline 主要起始原料 Tigecycline Metabolite M6 (9-Animominocycline)
  • (文献来源)合成步骤主要原料 Tigecycline Metabolite M6 (9-Animominocycline)
3,10,12,12A-Tetraacetylminocycline置于甲醇,Lithium Hydroxide体系中,化学反应 2.0H,以93%的收率获得米诺环素
参考文献:一种盐酸米诺环素的合成方法
标题:一种盐酸米诺环素的合成方法
摘要:本发明公开一种盐酸米诺环素的制备方法,其特征在于:以盐酸去甲基金霉素为起始原料,经过脱羟基反应得到6‑脱氧‑6‑去甲基金霉素(简称中间体i),中间体i经过乙酰基保护得到3,10,12,12A‑四乙酰基‑6‑脱氧‑6‑去甲基金霉素(简称中间体ii),中间体ii经过buchwald‑hartwig反应得到3,10,12,12A‑四乙酰基米诺环素(简称中间体iii),中间体iii经过水解得到米诺环素游离碱(简称中间体iv),中间体iv经过成盐得到盐酸米诺环素.本发明避免了传统盐酸米诺环素合成过程中使用的硝化,重氮化,偶氮化反应,降低了生产过程中的危险因素,操作简单,避免了环境污染,具有工业化生产的前景.

海关参考信息

专利信息


专利号:WO-2012047907-A9
优先权日:2010-10-04
标题 :Synthesis of c5-substituted tetracyclines, uses thereof, and intermediates thereto
发明人:MYERS ANDREW G; WRIGHT PETER M; HECKER EVAN
权利人:HARVARD COLLEGE; MYERS ANDREW G; WRIGHT PETER M; HECKER EVAN
摘要:The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics. The recent development of a modular synthesis of tetracycline analogs through a chiral enone intermediate has allowed for the efficient synthesis of novel tetracycline analogs never prepared before. The present invention provides more efficient routes for preparing the enone intermediate and allows for a wide variety of substituents at position 5 of the tetracycline ring system.

专利号:US-9688644-B2
优先权日:2009-04-30
标 题 :Synthesis of Tetracyclines and intermediates thereto
发明人:MYERS ANDREW G; KUMMER DAVID A; LI DERUN; HECKER EVAN; DION AMELIE; WRIGHT PETER M
权利人:HARVARD COLLEGE
摘要:The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics. The recent development of a modular synthesis of tetracycline analogs through a chiral enone intermediate has allowed for the efficient synthesis of novel tetracycline analogs never prepared before. The present invention provides more efficient routes for preparing the enone intermediate and allows for substituents at positions 4a, 5, 5a, and 12a of the tetracycline ring system.

专利号:US-9884830-B2
优先权日:2004-05-21
标题 :Synthesis of tetracyclines and analogues thereof
发明人:MYERS ANDREW G; CHAREST MARK G; LERNER CHRISTIAN D; BRUBAKER JASON D; SIEGEL DIONICIO R
权利人:HARVARD COLLEGE
摘要:The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics. The modular synthesis of tetracyclines and tetracycline analogs described provides an efficient and enantioselective route to a variety of tetracycline analogs and polycyclines previously inaccessible via earlier tetracycline syntheses and semi-synthetic methods. These analogs may be used as anti-microbial agents or anti-proliferative agents in the treatment of diseases of humans or other animals.

专利号:US-8907104-B2
优先权日:2006-10-11
标 题 :Synthesis of enone intermediate
发明人:MYERS ANDREW G; BRUBAKER JASON D
权利人:HARVARD COLLEGE
摘要:The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics. The recent development of a modular synthesis of tetracycline analogs through a chiral enone intermediate has allowed for the efficient synthesis of novel tetracycline analogs never prepared before. The present invention provides a more efficient route for preparing the enone intermediate.

专利号:US-10925977-B2
优先权日:2006-10-05
标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

专利号:US-2024197774-A1
优先权日:2021-04-16
标 题:Synthesis of Antimicrobial PVP-coated Bismuth Nanoparticles
发明人:LOPEZ-RIBOT JOSE; VAZQUEZ-MUNOZ ROBERTO
权利人:UNIV TEXAS
摘要:Described herein is a facile, fast, and economical method for the synthesis of BAL-mediated PVP-BiNPs, using basic laboratory instruments and reagents readily available in most laboratories.
南通嘉星泰生物科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jxtbio.com
企业联系电话:18795782766;13773776703👤
📞南通嘉星泰生物科技有限公司 ⚠️参考联系方式
联系人:蔡先生
电话:18795782766;13773776703

传真:0513-87503981
邮箱:297962169@qq.com
通信地址: 江苏省如皋市石庄镇张扬园村十组42号
邮编:
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江苏省如皋市石庄镇张扬园村十组42号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
杭州王隆科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.hzwangpro.com
企业联系电话:18969066569👤
📞杭州王隆科技有限公司 ⚠️参考联系方式
联系人:王经理
电话:18969066569
手机:18969066569
传真:0571-88089193
邮箱:yongchunwang@126.com
通信地址: 杭州市拱墅区新青年广场3-1509室
邮编: 310004
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:杭州市拱墅区新青年广场3-1509室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
天津国恩进出口贸易有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.gnchemicals.com
电话: 0311-85902108👤
📞天津国恩进出口贸易有限公司 ⚠️参考联系方式

销售电话:0311-85902108
邮箱:info@gnchemicals.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Garner SE, Eady A, Bennett C, Newton JN, Thomas K, Popescu CM. Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD002086. doi: 10.1002/14651858.CD002086.pub2.
2: Rosenblat JD, McIntyre RS. Efficacy and tolerability of minocycline for depression: A systematic review and meta-analysis of clinical trials. J Affect Disord. 2018 Feb;227:219-225. doi: 10.1016/j.jad.2017.10.042. Epub 2017 Oct 28. 4(2):137-45. 85(4):482-7. doi: 10.7326/0003-4819-85-4-482. 62(1597):68-70. 33(10):1215-1226. doi: 10.1177/0269881119858286. Epub 2019 Jul 11. 69(4):602-609. doi: 10.1016/j.pharep.2017.02.001. Epub 2017 Feb 8. 196(2):168-79. doi: 10.1016/j.bbr.2008.09.040. Epub 2008 Oct 11. 118(1):4-8. doi: 10.1111/bcpt.12444. Epub 2015 Aug 2. 11(5):327-41. doi: 10.2165/11319280-000000000-00000.

合成参考文献


摘要:American Journal of Medicine., 109(340), 2000 []
摘要:Chemotherapy, 26(196), 1980 []
摘要:Antibiotics: Origin, Nature, and Properties, Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978, 1(501), 1978
摘要:S72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664
摘要:S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (2021) DOI:10.1021/acsenvironau.1c00008. List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知